Arthroscopic Infrapatellar Fat Pad Release and Mesenchymal Stem Cell Mobilization
IP-MSC-RELEASE
Arthroscopic Mechanical Release of the Infrapatellar Fat Pad Mobilizes Cells With a Mesenchymal Stem Cell Immunophenotype and Alters Early Molecular Responses.
1 other identifier
interventional
26
1 country
1
Brief Summary
This prospective, single-center, paired-sample clinical laboratory study evaluated whether controlled mechanical release of the infrapatellar fat pad during knee arthroscopy increases the number of intra-articular cells with a mesenchymal stem cell immunophenotype. The study also evaluated whether the procedure is accompanied by immediate changes in the expression of selected genes associated with inflammation, immunomodulation, and tissue repair. Adults undergoing knee arthroscopy for meniscal pathology had a 20-mL intra-articular fluid sample collected before manipulation of any intra-articular structure. The infrapatellar fat pad was then gently and selectively shaved for approximately 1 minute using a motorized arthroscopic shaver with the suction turned off. A second 20-mL intra-articular fluid sample was collected immediately after the procedure and before further irrigation or continuation of the planned arthroscopic surgery. Paired pre-release and post-release samples were analyzed by flowcytometry to quantify cells with a mesenchymal stem cell immunophenotype. Quantitative real-time polymerase chain reaction was performed on the total cellular fraction to assess IL-1β, IL-6, IL-10, TGF-β, and CD24 gene expression. Comparisons were performed within each participant using the paired samples.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2025
CompletedFirst Submitted
Initial submission to the registry
July 27, 2026
CompletedFirst Posted
Study publicly available on registry
July 30, 2026
CompletedJuly 30, 2026
July 1, 2026
1 year
July 27, 2026
July 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Cells With a Mesenchymal Stem Cell Immunophenotype Before and After Infrapatellar Fat Pad Release
The number of LIN-negative, CD29-positive, CD73-positive, CD13-positive, CD105-positive, CD90-positive, and CD31-negative cells was quantified by flow cytometry in standardized paired intra-articular fluid samples collected before and immediately after controlled mechanical release of the infrapatellar fat pad. Paired cell counts were summarized as median with minimum and maximum values and compared within participants.
Immediately before and immediately after the approximately 1-minute infrapatellar fat pad release procedure during the same knee arthroscopy
Secondary Outcomes (5)
Fold Change in IL-1β Gene Expression After Infrapatellar Fat Pad Release
Immediately before and immediately after the approximately 1-minute infrapatellar fat pad release procedure during the same knee arthroscopy
Fold Change in IL-6 Gene Expression After Infrapatellar Fat Pad Release
Immediately before and immediately after the approximately 1-minute infrapatellar fat pad release procedure during the same knee arthroscopy
Fold Change in IL-10 Gene Expression After Infrapatellar Fat Pad Release
Immediately before and immediately after the approximately 1-minute infrapatellar fat pad release procedure during the same knee arthroscopy
Fold Change in TGF-β Gene Expression After Infrapatellar Fat Pad Release
Immediately before and immediately after the approximately 1-minute infrapatellar fat pad release procedure during the same knee arthroscopy
Fold Change in CD24 Gene Expression After Infrapatellar Fat Pad Release
Immediately before and immediately after the approximately 1-minute infrapatellar fat pad release procedure during the same knee arthroscopy
Study Arms (1)
Arthroscopic Infrapatellar Fat Pad Release
EXPERIMENTALParticipants undergoing routine knee arthroscopy for meniscal pathology underwent paired intra-articular fluid sampling. A 20-mL baseline sample was collected before any intra-articular manipulation. The infrapatellar fat pad was then gently and selectively shaved for approximately 1 minute using a motorized arthroscopic shaver with the suction temporarily turned off. A second 20-mL intra-articular fluid sample was collected immediately after shaving and before further irrigation. The released tissue was subsequently removed using routine arthroscopic suction and irrigation, and the planned arthroscopic procedure was completed.
Interventions
After baseline intra-articular fluid sampling, the infrapatellar fat pad was gently and selectively shaved for approximately 1 minute with the motorized arthroscopic shaver suction temporarily turned off. A second intra-articular fluid sample was collected immediately after shaving and before further irrigation. The released tissue was subsequently removed using routine arthroscopic suction and irrigation. No released tissue or cells were intentionally retained in the joint for therapeutic purposes.
Eligibility Criteria
You may qualify if:
- Age between 18 and 55 years
- Presence of knee pain
- Meniscal tear confirmed by magnetic resonance imaging
- Scheduled to undergo arthroscopic knee surgery
- Provision of written informed consent to participate in the study
You may not qualify if:
- Requirement for emergency surgery
- Open injury involving the knee
- Severe anterior or posterior cruciate ligament injury causing substantial knee instability
- Tibial eminence fracture
- Osteochondral defect requiring surgical treatment
- Planned open knee surgery
- Suspected septic arthritis
- Inflammatory arthritis
- Suspected intra-articular tumor
- Previous arthroscopic surgery on the same knee
- Declining to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Bilkent City Hospital
Ankara, Ankara, 06800, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ibrahim a yavuz, MD, PhD
Ankara Bilkent City Hospital, Department of Orthopedics and Traumatology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Orthopaedics and Traumatology
Study Record Dates
First Submitted
July 27, 2026
First Posted
July 30, 2026
Study Start
January 9, 2024
Primary Completion
January 10, 2025
Study Completion
January 10, 2025
Last Updated
July 30, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because specific participant consent for external data sharing was not obtained.